DeFi Development Corp. enters the final stretch before its May 13 earnings report in an unusual position: short sellers are quietly retreating, the stock is recovering, and yet the borrow market remains one of the most charged in the consumer finance space. The tension between a lightening short base and still-elevated conviction from remaining bears is the central story heading into Q1 results.
Short interest tells a tale of persistent pressure that is slowly but unmistakably unwinding. Short Interest % of Free Float peaked above 31% in late March and early April, when borrow availability was at its tightest all year. It has since declined to 27.8% of the free float — a meaningful 3.5 percentage point drop over six weeks. The official FINRA figure from mid-April confirms the picture: roughly 5.99 million shares short, with days-to-cover at 6.1. That is still a heavy load for a stock trading around $4.55. Shorts have reduced exposure by about 8.5% over the past month, yet the remaining position is large enough that any acceleration of that covering process would create real upward pressure on the price.
The borrow market is tight but loosening. Cost to borrow ran above 26% annualised in early April — among the highest levels of the past two months — and has eased to just under 20% now. That is still expensive, not the frictionless lending environment you see on names where shorts have full conviction. The lending pool availability has also expanded from near-zero in late March, when the borrow market was essentially locked. The ORTEX short score of 81.9 is elevated, placing in the upper tier of its universe on combined short pressure metrics. That score has barely moved all week, suggesting the repositioning underway is orderly rather than a panicked exit. Options traders are not yet concerned: the put/call ratio of 0.19 is slightly above its 20-day average of 0.145, but well within normal range and nowhere near the 0.83 52-week high. Calls dominate the order flow heavily, which is consistent with a speculative long base betting on further recovery.
Vanguard and BlackRock are both on the register and added shares in Q1 2026, which gives the stock a degree of institutional legitimacy that smaller DeFi-adjacent names often lack. Vanguard added 526,000 shares to reach a 4.3% position as recently as March 31. Millennium and Two Sigma both established fresh positions in the December quarter, another indication that quantitative and hedge-fund interest in the name is broadening. On the insider side, the 90-day net activity is modestly positive at roughly 23,000 shares and just under $89,000 in net value — but the composition matters more than the aggregate. The CFO sold small parcels in both March and April at prices that were above the current level, while the founder Blake Janover received a 70,000-share award in April and immediately sold 17,000 shares at $3.45. Neither transaction signals conviction buying by management. The most recent insider purchases of note — COO Parker White adding roughly $150,000 worth of shares in November and December at prices between $5.76 and $6.94 — are now underwater relative to where the stock was bought.
Prior earnings prints have been rough in the near term. The last three events triggered same-day moves of -2.3%, -0.6%, and -7.6% respectively. The five-day recoveries were more mixed: one event produced an 11.8% rebound in the week that followed, while another ended flat. That is not a pattern that commands premium for holders heading into May 13, but it does suggest the stock can recover from the initial reaction if nothing fundamental surprises.
The analyst picture is sparse. The only coverage in the data is a Cantor Fitzgerald initiation from June 2025 with an Overweight rating and a $45 target — a figure that is both stale and far removed from where the stock actually trades. That target should not be used as a reference point for current positioning. With just one dated coverage record, the Street offers no fresh signal in either direction.
The next test is the Q1 report on May 13. Watch whether short interest continues its steady decline in the two weeks prior — sustained covering into earnings would validate the recovery narrative — or whether fresh shorts rebuild as the announcement approaches and the stock retests resistance near its one-month highs.
See the live data behind this article on ORTEX.
Open DFDV on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
